Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CCKBR | P32239 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24939801 | 0.78 | MEN1 (0.44) | SMN1; SMN2MEN1KMT2A | |
| SCHEMBL24939688 | 0.76 | ALDH1A1 (0.62) | TSHRALDH1A1PKMSMN1; SMN2MAPK1 | |
| SCHEMBL24939690 | 0.75 | TSHR (0.39) | LMNATSHRALDH1A1PKMSMN1; SMN2 | |
| SCHEMBL18539434 | 0.71 | PTGS1 (0.54) | LMNATSHRALDH1A1PKMSMN1; SMN2 | |
| SCHEMBL17467862 | 0.69 | APEX1 (0.44) | LMNAALDH1A1MEN1KMT2APOLB | |
| SCHEMBL24939802 | 0.68 | TSHR (0.42) | TSHRALDH1A1PKMSMN1; SMN2MEN1 | |
| SCHEMBL24939794 | 0.66 | TSHR (0.38) | TSHRALDH1A1PKMSMN1; SMN2MAPK1 | |
| SCHEMBL409092 | 0.65 | LMNA (0.53) | LMNATSHRALDH1A1MAPK1TDP1 | |
| SCHEMBL11593236 | 0.64 | CYP1A2 (0.53) | LMNATSHRALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL24939793 | 0.64 | TSHR (0.37) | LMNATSHRALDH1A1PKMSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230022129-A1 | RESIST MATERIAL AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230022129-A1 | RESIST MATERIAL AND PATTERNING PROCESS | GFER, LBR, PCNA | LMNA 1223/4885TSHR 4501/4885ALDH1A1 3757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.